Sangamo Therapeutics (SGMO) Q1 2025 Earnings Call May 12, 2025 06:30 PM ET Company Participants Louise Wilkie - Head - IR & Corporate CommunicationsSandy Macrae - President & Chief Executive OfficerPrathyusha Duraibabu - CFONathalie Dubois-Stringfellow - Chief Development OfficerLuis Santos - Senior Equity Research Associate, Healthcare & Biotechnology Conference Call Participants James Vane-Tempest - Senior Equity AnalystNicole Germino - Stock AnalystNone - AnalystLuca Issi - Senior Biotechnology Analyst O ...